Skip navigation

BioWednesday London: Does Every Tech Transfer Office Need an Investment Fund?

Registration for this event is now closed. If you would like to be added to a waiting list for this event please contact nadia@onenucleus.com

Location:
EIP, Fairfax House, 15 Fulwood Place, London. WC1V 6HU
Date:
04 May 2016
 

Commercialisation of IP from academic research requires a number of key elements such as the correct protection or registration of the invention, appropriate evaluation of the opportunity and sufficient data to secure further investment or a licensee. The ever increasing demand for supportive data has led a number of institutions to establish their own investment funds, either alone or in syndication with others. This event will here form examples of such funds and debate if this is now an essential mechanism for effective commercialisation of IP.

Programme:
18.00  Registration and networking over tea and coffee

18.30  Welcome

18.35  Establishing the UCL Technology and Apollo Therapeutics Funds 
Anne Lane, Executive Director, UCL Business
Click here to view the presentation

18.55  Panel Discussion: “Do all technology transfer offices need an in-house investment fund?”
Chair:  Andrew Sharples, EIP

Panel: Anne Lane, Executive Director, UCL Business
Bradley Hardiman, Investment Manager, Cambridge Enterprise
David Baynes, COO, IP Group
Morris Berrie, Co-Chairman, Tech Transfer Global Initiative and Director, Tech Investor

Money Mover Presentation
Click here to view the presentation

19.35  Closing Remarks

19.40  Networking over drinks & canapes

21.00  Close

Prices:

Members - free 
Non-member - £50 + VAT
Academics and students - contact nadia@onenucleus.com
Title: BioWednesday London: Does Every Tech Transfer Office Need an Investment Fund?
Start: 2016-05-04 18:00:00Z
End: 2016-05-04 21:00:00Z